Life ScienceCompany
Who owns Xpress Biologics?
Xpress Biologics is owned by Polyplus-transfection SA. It was acquired in 2022.
Xpress Biologics is owned by Polyplus-transfection SA. It was acquired in 2022.
Accessia Pharma site Avenue du Parc Industriel, 89,
Milmort,
4041
Belgium,
+32 (0) 4 346 00 20
www.xpress-biologics.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Current | 2022-12-07 | Polyplus | |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.